CHRISTINEJOY DOLIENTE: Open Payments
NPI 1649053455 · ESCONDIDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $858 · 2025 $914
Food & beverage: $913Travel & lodging: $1
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $287 |
| Lilly USA, LLC | 3 | $246 |
| Lundbeck LLC | 1 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $106 |
| Alexion Pharmaceuticals, Inc. | 2 | $46 |
| ARGENX US, INC. | 2 | $42 |
| ABBVIE INC. | 2 | $39 |
| Grifols USA, LLC | 1 | $31 |
Products named: AMVUTTRA, KISUNLA, VYEPTI, SPEVIGO, ULTOMIRIS, VYVGART, SKYRIZI, Prolastin-C Liquid.
Industry payments across CA — which companies pay providers there.
